Clinical Trials Directory

Trials / Unknown

UnknownNCT04574791

Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Rothman Institute Orthopaedics · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This is a prospective, cluster-randomized, two-arm, comparative study aimed at determining whether addition of tizanidine ( an oral muscle relaxant) to a multimodal pain regimen following primary TKA reduces opioid consumption.

Conditions

Interventions

TypeNameDescription
DRUGTiZANidine 2 MG Oral CapsuleTizanidine 2 mg q8h (standing; # 42 tablets) + Multimodal pain regimen

Timeline

Start date
2020-09-03
Primary completion
2021-09-30
Completion
2021-09-30
First posted
2020-10-05
Last updated
2020-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04574791. Inclusion in this directory is not an endorsement.